Class information for:
Level 1: TRICHOMEGALY//EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS//SKIN TOXICITY

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
16698 641 33.1 81%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
216 3       NON SMALL CELL LUNG CANCER//LUNG CANCER//THORAC SURG 51214
3290 2             HAND FOOT SYNDROME//HYPERSENSITIVITY REACTION//RADIATION RECALL 1872
16698 1                   TRICHOMEGALY//EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS//SKIN TOXICITY 641

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 TRICHOMEGALY authKW 771696 3% 90% 18
2 EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS authKW 629914 6% 37% 36
3 SKIN TOXICITY authKW 521861 7% 26% 42
4 ACNEIFORM ERUPTION authKW 453924 3% 53% 18
5 PAPULOPUSTULAR ERUPTION authKW 333451 1% 100% 7
6 PARONYCHIA authKW 331538 4% 30% 23
7 CUTANEOUS SIDE EFFECTS authKW 270974 2% 36% 16
8 ACNEIFORM RASH authKW 264634 2% 56% 10
9 EGFRI authKW 259347 1% 78% 7
10 PAPULOPUSTULAR RASH authKW 259347 1% 78% 7

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Dermatology 15052 37% 0% 236
2 Oncology 3341 38% 0% 243
3 Ophthalmology 314 7% 0% 42
4 Health Care Sciences & Services 202 4% 0% 27
5 Rehabilitation 167 4% 0% 24
6 Nursing 92 2% 0% 16
7 Hematology 53 4% 0% 23
8 Allergy 15 1% 0% 6
9 Toxicology 10 2% 0% 13
10 Pharmacology & Pharmacy 7 5% 0% 31

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SERIES CLIN 194507 1% 58% 7
2 HEPATOGASTROENTEROL GASTROINTESTINAL ONCOL 107179 0% 75% 3
3 CANC SKIN CARE PROGRAM 95272 0% 100% 2
4 NW MEM FDN 63513 0% 67% 2
5 ALLERGOL VENEROL HAUTTUMORZENTRUM HANNOVER 47636 0% 100% 1
6 AZIENDA SERV SANIT 47636 0% 100% 1
7 CANC SKIN CARE PROG 47636 0% 100% 1
8 CARCINOGENESIS TRANSLAT MINIST ED 47636 0% 100% 1
9 CHEF SERV DERMATOL 47636 0% 100% 1
10 CHULALONGKORN ALLERGY CLIN IMMUNOL GRP 47636 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SUPPORTIVE CARE IN CANCER 5864 4% 1% 23
2 HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY 5073 1% 3% 4
3 CUTANEOUS AND OCULAR TOXICOLOGY 4950 1% 1% 8
4 ONCOLOGIST 3622 2% 1% 13
5 DERMATOLOGY 3395 3% 0% 17
6 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 3031 4% 0% 28
7 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 2690 3% 0% 18
8 AMERICAN JOURNAL OF CLINICAL DERMATOLOGY 2321 1% 1% 6
9 JOURNAL OF DRUGS IN DERMATOLOGY 2295 1% 1% 9
10 CLINICAL JOURNAL OF ONCOLOGY NURSING 2110 1% 1% 6

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 TRICHOMEGALY 771696 3% 90% 18 Search TRICHOMEGALY Search TRICHOMEGALY
2 EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS 629914 6% 37% 36 Search EPIDERMAL+GROWTH+FACTOR+RECEPTOR+INHIBITORS Search EPIDERMAL+GROWTH+FACTOR+RECEPTOR+INHIBITORS
3 SKIN TOXICITY 521861 7% 26% 42 Search SKIN+TOXICITY Search SKIN+TOXICITY
4 ACNEIFORM ERUPTION 453924 3% 53% 18 Search ACNEIFORM+ERUPTION Search ACNEIFORM+ERUPTION
5 PAPULOPUSTULAR ERUPTION 333451 1% 100% 7 Search PAPULOPUSTULAR+ERUPTION Search PAPULOPUSTULAR+ERUPTION
6 PARONYCHIA 331538 4% 30% 23 Search PARONYCHIA Search PARONYCHIA
7 CUTANEOUS SIDE EFFECTS 270974 2% 36% 16 Search CUTANEOUS+SIDE+EFFECTS Search CUTANEOUS+SIDE+EFFECTS
8 ACNEIFORM RASH 264634 2% 56% 10 Search ACNEIFORM+RASH Search ACNEIFORM+RASH
9 EGFRI 259347 1% 78% 7 Search EGFRI Search EGFRI
10 PAPULOPUSTULAR RASH 259347 1% 78% 7 Search PAPULOPUSTULAR+RASH Search PAPULOPUSTULAR+RASH

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 MACDONALD, JB , MACDONALD, B , GOLITZ, LE , LORUSSO, P , SEKULIC, A , (2015) CUTANEOUS ADVERSE EFFECTS OF TARGETED THERAPIES PART I: INHIBITORS OF THE CELLULAR MEMBRANE.JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. VOL. 72. ISSUE 2. P. 203 -218 72 55% 17
2 POTTHOFF, K , HOFHEINZ, R , HASSEL, JC , VOLKENANDT, M , LORDICK, F , HARTMANN, JT , KARTHAUS, M , RIESS, H , LIPP, HP , HAUSCHILD, A , ET AL (2011) INTERDISCIPLINARY MANAGEMENT OF EGFR-INHIBITOR-INDUCED SKIN REACTIONS: A GERMAN EXPERT OPINION.ANNALS OF ONCOLOGY. VOL. 22. ISSUE 3. P. 524 -535 34 83% 47
3 BALAGULA, Y , GARBE, C , MYSKOWSKI, PL , HAUSCHILD, A , RAPOPORT, BL , BOERS-DOETS, CB , LACOUTURE, ME , (2011) CLINICAL PRESENTATION AND MANAGEMENT OF DERMATOLOGICAL TOXICITIES OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS.INTERNATIONAL JOURNAL OF DERMATOLOGY. VOL. 50. ISSUE 2. P. 129 -146 41 67% 16
4 BACHMEYER, C , REGUIAI, Z , PEUVREL, L , BACHET, JB , BENSADOUN, RJ , YCHOU, M , ANDRE, T , BOUCHE, O , DRENO, B , (2013) CUTANEOUS ADVERSE REACTIONS OF EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR)-INHIBITORS: THERAPEUTIC ALGORITHM OF THE FRENCH PROCUR GROUP.BULLETIN DU CANCER. VOL. 100. ISSUE 5. P. 417-426 26 93% 0
5 OCVIRK, J , HEEGER, S , MCCLOUD, P , HOFHEINZ, RD , (2013) A REVIEW OF THE TREATMENT OPTIONS FOR SKIN RASH INDUCED BY EGFR-TARGETED THERAPIES: EVIDENCE FROM RANDOMIZED CLINICAL TRIALS AND A META-ANALYSIS.RADIOLOGY AND ONCOLOGY. VOL. 47. ISSUE 2. P. 166 -175 32 68% 17
6 WU, PA , BALAGULA, Y , LACOUTURE, ME , ANADKAT, MJ , (2011) PROPHYLAXIS AND TREATMENT OF DERMATOLOGIC ADVERSE EVENTS FROM EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS.CURRENT OPINION IN ONCOLOGY. VOL. 23. ISSUE 4. P. 343 -351 28 80% 10
7 COHEN, PR , ESCUDIER, SM , KURZROCK, R , (2011) CETUXIMAB-ASSOCIATED ELONGATION OF THE EYELASHES CASE REPORT AND REVIEW OF EYELASH TRICHOMEGALY SECONDARY TO EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS.AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. VOL. 12. ISSUE 1. P. 63-67 24 92% 11
8 WALLNER, M , KOCK-HODI, S , BOOZE, S , WHITE, KJ , MAYER, H , (2016) NURSING MANAGEMENT OF CUTANEOUS TOXICITIES FROM EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS.CLINICAL JOURNAL OF ONCOLOGY NURSING. VOL. 20. ISSUE 5. P. 529 -536 26 79% 0
9 PETRELLI, F , BORGONOVO, K , CABIDDU, M , COINU, A , GHILARDI, M , LONATI, V , BARNI, S , (2016) ANTIBIOTIC PROPHYLAXIS FOR SKIN TOXICITY INDUCED BY ANTIEPIDERMAL GROWTH FACTOR RECEPTOR AGENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS.BRITISH JOURNAL OF DERMATOLOGY. VOL. 175. ISSUE 6. P. 1166 -1174 23 77% 1
10 LIVINGSTONE, E , TRARBACH, T , ZIMMER, L , SCHULER, M , SCHADENDORF, D , (2011) INTERDISCIPLINARY MANAGEMENT OF CUTANEOUS ADVERSE EVENTS OF EGFR INHIBITORS AND MULTITYROSINE KINASE INHIBITORS IN ONCOLOGY.DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. VOL. 136. ISSUE 1-2. P. 39 -44 27 77% 3

Classes with closest relation at Level 1


Rank Class id link
1 14182 HAND FOOT SYNDROME//RADIATION RECALL//RADIATION RECALL DERMATITIS
2 2234 PANITUMUMAB//CETUXIMAB//KRAS
3 4440 NIMOTUZUMAB//CETUXIMAB//EGFR
4 23624 RADIATION DERMATITIS//RADIODERMATITIS//MOIST DESQUAMATION
5 147 GEFITINIB//EGFR MUTATION//ERLOTINIB
6 25313 SCALP COOLING//CHEMOTHERAPY INDUCED ALOPECIA//ALOPECIA
7 727 SUNITINIB//METASTATIC RENAL CELL CARCINOMA//RENAL CELL CARCINOMA
8 13756 HB EGF//AMPHIREGULIN//HEPARIN BINDING EPIDERMAL GROWTH FACTOR LIKE GROWTH FACTOR
9 35514 AG 1295//BONE CANC SMYELOMA//CAREGGI UNIV HOSP INTERNAL MEDAOU CAREGGI
10 1284 VEMURAFENIB//BRAF INHIBITOR//BRAF

Go to start page